BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Schrier R, Dahan JDC, Boon M, Sarton E, van Velzen M, Niesters M, Dahan A. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. Anesthesiology 2021. [PMID: 34958670 DOI: 10.1097/ALN.0000000000004096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Razlansari M, Ulucan-Karnak F, Kahrizi M, Mirinejad S, Sargazi S, Mishra S, Rahdar A, Díez-Pascual AM. Nanobiosensors for detection of opioids: A review of latest advancements. Eur J Pharm Biopharm 2022:S0939-6411(22)00182-5. [PMID: 36067954 DOI: 10.1016/j.ejpb.2022.08.017] [Reference Citation Analysis]
2 Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A. Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression? Pharmacol Res Perspect 2022;10:e00974. [PMID: 35621218 DOI: 10.1002/prp2.974] [Reference Citation Analysis]
3 Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A. Respiratory effects of thyrotropin-releasing hormone and its analogue taltirelin on opioid-induced respiratory depression. Br J Anaesth 2022:S0007-0912(22)00147-7. [PMID: 35459532 DOI: 10.1016/j.bja.2022.03.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]